Jasper Therapeutics Inc.
(JSPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 15,993 | 15,072 | 17,725 | 19,362 | 17,827 |
| Operating Income | -15,993 | -15,072 | -17,725 | -19,362 | -17,827 |
| Other Income | 1,410 | 1,344 | 1,144 | 1,818 | 1,747 |
| Pre-tax Income | -14,583 | -13,728 | -16,581 | -17,544 | -16,080 |
| Net Income Continuous | -14,583 | -13,728 | -16,581 | -17,544 | -16,080 |
| Net Income | $-14,583 | $-13,728 | $-16,581 | $-17,544 | $-16,080 |
| EPS Basic Total Ops | -0.97 | -1.03 | -1.49 | -1.60 | -1.47 |
| EPS Basic Continuous Ops | -0.97 | -1.03 | -1.48 | -1.60 | -1.47 |
| EPS Diluted Total Ops | -0.97 | -1.03 | -1.49 | -1.60 | -1.47 |
| EPS Diluted Continuous Ops | -0.97 | -1.03 | -1.48 | -1.60 | -1.47 |
| EPS Diluted Before Non-Recurring Items | -0.97 | -1.03 | -1.50 | N/A | N/A |
| EBITDA(a) | $-15,694 | $-14,784 | $-17,442 | $-19,086 | $-17,552 |